We are live on ! Find out more
Tweedy, Browne Co

Tweedy, Browne Co Portfolio holdings

AUM $1.23B Turnover 16.5%
1-Year Est. Return 16.54%
This Fund
S&P 500
This Quarter Est. Return
-0.85%
1 Year Est. Return
+16.54%
3 Year Est. Return
+68.01%
5 Year Est. Return
+84.21%
10 Year Est. Return
+240.14%
AUM
$1.23B
AUM Growth
-$91.5M
Cap. Flow
-$32.1M
Cap. Flow %
-2.61%
Top 10 Hldgs %
67.14%
Holding
103
New
12
Increased
47
Reduced
33
Closed
5
Avg Time Held
3.9 years
Top 10 Avg Time Held
6 years
Top 20 Avg Time Held
5.5 years

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$19.1M
2
ZTS icon
Zoetis
ZTS
+$7.25M
3
ADBE icon
Adobe
ADBE
+$2.79M
4
DKS icon
Dick's Sporting Goods
DKS
+$2.7M
5
NOMD icon
Nomad Foods
NOMD
+$2.63M

Top Sells

Rank Stock Value
1
IONS icon
Ionis Pharmaceuticals
IONS
+$27.7M
2
UNF icon
Unifirst Corp
UNF
+$18.7M
3
CNH icon
CNH Industrial
CNH
+$9.29M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.22M
5
ALV icon
Autoliv
ALV
+$5.88M

Sector Composition

Rank Sector Weight
1 Industrials 24.65%
2 Financials 23.81%
3 Healthcare 21.5%
4 Consumer Staples 12.09%
5 Consumer Discretionary 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KT icon
101
KT
KT
$8.98B
– –
-222,892
Closed -$3.85M –
PNC icon
102
PNC Financial Services
PNC
$92.3B
– –
-13,214
Closed -$3.25M –
FDXF icon
103
FedEx Freight
FDXF
$20B
– –
-2,206
Closed -$333K –

Similar funds

Tweedy, Browne Co's Q3 2026 Portfolio in Review

As of Q3 2026, Tweedy, Browne Co held 103 positions worth $1.23B, down 6.9% from $1.32B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Tweedy, Browne Co's Q3 2026 filing shows 12 new, 47 increased, 33 reduced and 5 closed positions. Its largest new stake was Aptiv: 377,133 shares worth $16.2M. The largest sale was Ionis Pharmaceuticals, an estimated $27.7M.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Tweedy, Browne Co's largest Q3 2026 buy was Aptiv: 377,133 shares worth $16.2M.
  • Tweedy, Browne Co added most to Zoetis in Q3 2026, an estimated $7.25M increase.
  • Tweedy, Browne Co's biggest Q3 2026 reduction was Ionis Pharmaceuticals, cutting an estimated $27.7M.
  • Tweedy, Browne Co fully exited KT in Q3 2026, selling an estimated $3.85M.
  • Tweedy, Browne Co's ten largest holdings make up 67% of its $1.23B portfolio in Q3 2026.
  • Tweedy, Browne Co opened 12 new positions and closed 5 in Q3 2026.
  • Tweedy, Browne Co's portfolio value fell 6.9% quarter-over-quarter to $1.23B.

Based on Tweedy, Browne Co's 13F filing for Q3 2026, filed 4 Nov 2026.